Concurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant
Abstract The D614G mutation in the Spike protein of the SARS-CoV-2 has effectively replaced the early pandemic-causing variant. Using pseudotyped lentivectors, we confirmed that the aspartate replacement by glycine in position 614 is markedly more infectious. Molecular modelling suggests that the G6...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/425fb19c933a4ad18acbebcbf3e961d0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:425fb19c933a4ad18acbebcbf3e961d0 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:425fb19c933a4ad18acbebcbf3e961d02021-12-02T18:18:58ZConcurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant10.1038/s41598-021-91662-w2045-2322https://doaj.org/article/425fb19c933a4ad18acbebcbf3e961d02021-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-91662-whttps://doaj.org/toc/2045-2322Abstract The D614G mutation in the Spike protein of the SARS-CoV-2 has effectively replaced the early pandemic-causing variant. Using pseudotyped lentivectors, we confirmed that the aspartate replacement by glycine in position 614 is markedly more infectious. Molecular modelling suggests that the G614 mutation facilitates transition towards an open state of the Spike protein. To explain the epidemiological success of D614G, we analysed the evolution of 27,086 high-quality SARS-CoV-2 genome sequences from GISAID. We observed striking coevolution of D614G with the P323L mutation in the viral polymerase. Importantly, the exclusive presence of G614 or L323 did not become epidemiologically relevant. In contrast, the combination of the two mutations gave rise to a viral G/L variant that has all but replaced the initial D/P variant. Our results suggest that the P323L mutation, located in the interface domain of the RNA-dependent RNA polymerase, is a necessary alteration that led to the epidemiological success of the present variant of SARS-CoV-2. However, we did not observe a significant correlation between reported COVID-19 mortality in different countries and the prevalence of the Wuhan versus G/L variant. Nevertheless, when comparing the speed of emergence and the ultimate predominance in individual countries, it is clear that the G/L variant displays major epidemiological supremacy over the original variant.Sten IlmjärvFabien AbdulSilvia Acosta-GutiérrezCarolina EstarellasIoannis GaldadasMarina CasimirMarco AlessandriniFrancesco Luigi GervasioKarl-Heinz KrauseNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-13 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Sten Ilmjärv Fabien Abdul Silvia Acosta-Gutiérrez Carolina Estarellas Ioannis Galdadas Marina Casimir Marco Alessandrini Francesco Luigi Gervasio Karl-Heinz Krause Concurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant |
description |
Abstract The D614G mutation in the Spike protein of the SARS-CoV-2 has effectively replaced the early pandemic-causing variant. Using pseudotyped lentivectors, we confirmed that the aspartate replacement by glycine in position 614 is markedly more infectious. Molecular modelling suggests that the G614 mutation facilitates transition towards an open state of the Spike protein. To explain the epidemiological success of D614G, we analysed the evolution of 27,086 high-quality SARS-CoV-2 genome sequences from GISAID. We observed striking coevolution of D614G with the P323L mutation in the viral polymerase. Importantly, the exclusive presence of G614 or L323 did not become epidemiologically relevant. In contrast, the combination of the two mutations gave rise to a viral G/L variant that has all but replaced the initial D/P variant. Our results suggest that the P323L mutation, located in the interface domain of the RNA-dependent RNA polymerase, is a necessary alteration that led to the epidemiological success of the present variant of SARS-CoV-2. However, we did not observe a significant correlation between reported COVID-19 mortality in different countries and the prevalence of the Wuhan versus G/L variant. Nevertheless, when comparing the speed of emergence and the ultimate predominance in individual countries, it is clear that the G/L variant displays major epidemiological supremacy over the original variant. |
format |
article |
author |
Sten Ilmjärv Fabien Abdul Silvia Acosta-Gutiérrez Carolina Estarellas Ioannis Galdadas Marina Casimir Marco Alessandrini Francesco Luigi Gervasio Karl-Heinz Krause |
author_facet |
Sten Ilmjärv Fabien Abdul Silvia Acosta-Gutiérrez Carolina Estarellas Ioannis Galdadas Marina Casimir Marco Alessandrini Francesco Luigi Gervasio Karl-Heinz Krause |
author_sort |
Sten Ilmjärv |
title |
Concurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant |
title_short |
Concurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant |
title_full |
Concurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant |
title_fullStr |
Concurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant |
title_full_unstemmed |
Concurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant |
title_sort |
concurrent mutations in rna-dependent rna polymerase and spike protein emerged as the epidemiologically most successful sars-cov-2 variant |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/425fb19c933a4ad18acbebcbf3e961d0 |
work_keys_str_mv |
AT stenilmjarv concurrentmutationsinrnadependentrnapolymeraseandspikeproteinemergedastheepidemiologicallymostsuccessfulsarscov2variant AT fabienabdul concurrentmutationsinrnadependentrnapolymeraseandspikeproteinemergedastheepidemiologicallymostsuccessfulsarscov2variant AT silviaacostagutierrez concurrentmutationsinrnadependentrnapolymeraseandspikeproteinemergedastheepidemiologicallymostsuccessfulsarscov2variant AT carolinaestarellas concurrentmutationsinrnadependentrnapolymeraseandspikeproteinemergedastheepidemiologicallymostsuccessfulsarscov2variant AT ioannisgaldadas concurrentmutationsinrnadependentrnapolymeraseandspikeproteinemergedastheepidemiologicallymostsuccessfulsarscov2variant AT marinacasimir concurrentmutationsinrnadependentrnapolymeraseandspikeproteinemergedastheepidemiologicallymostsuccessfulsarscov2variant AT marcoalessandrini concurrentmutationsinrnadependentrnapolymeraseandspikeproteinemergedastheepidemiologicallymostsuccessfulsarscov2variant AT francescoluigigervasio concurrentmutationsinrnadependentrnapolymeraseandspikeproteinemergedastheepidemiologicallymostsuccessfulsarscov2variant AT karlheinzkrause concurrentmutationsinrnadependentrnapolymeraseandspikeproteinemergedastheepidemiologicallymostsuccessfulsarscov2variant |
_version_ |
1718378150812975104 |